Cargando…
A case report of locally invasive Aspergillus fumigatus infection in a patient on canakinumab
BACKGROUND: Canakinumab is a human monoclonal interleukin-1 antibody that has been studied in the Canakinumab Anti-Inflammatory Thrombosis Outcome Study (CANTOS) trial and shown to prevent recurrent cardiovascular events, while increasing the incidence of neutropenia and risk of severe infections. C...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177092/ https://www.ncbi.nlm.nih.gov/pubmed/31020175 http://dx.doi.org/10.1093/ehjcr/yty098 |